Brain-derived neurotrophic factor and post-stroke depression.

Journal of Neuroscience Research
Eric Zhang, Ping Liao

Abstract

Brain-derived neurotrophic factor (BDNF) is well known to play a critical role in cognition. Its role in mood disorders, including post stroke depression (PSD), is also recognized with more evidence surfacing. In patients with PSD, their serum BNDF level is lower than in those without depression. Furthermore, antidepressants could enhance BDNF expression in the brain, resulting in an alleviation of depression symptoms. Such therapeutic effect can be abolished in animals with the BDNF gene deleted. In PSD patients, the presence of stroke may contribute to the development of depression, including affecting the expression of BDNF. However, the mechanisms of BDNF in the development of PSD remain largely unknown. Lower BDNF levels may have existed in some patients before stroke onset, making them vulnerable to develop depressive symptoms. Meanwhile, the hypoxic environment induced by stroke could possibly downregulate BDNF expression in the brain. Current antidepressant treatments are not specific for PSD and there is a lack of treatments to address the linkage between stroke and PSD. This review summarizes the current knowledge of BDNF in PSD. By regulating BDNF expression, a synergistic effect may be achieved when such treatments ...Continue Reading

References

Oct 1, 1977·Journal of Neurology, Neurosurgery, and Psychiatry·M F FolsteinP R McHugh
May 1, 1981·Annals of Neurology·R G Robinson, B Szetela
Oct 24, 1997·Archives of General Psychiatry·G S AlexopoulosM Charlson
May 14, 1999·Current Opinion in Neurobiology·R J DavidsonK Putnam
Aug 11, 2001·Science·P A Jones, D Takai
Oct 5, 2002·Stroke; a Journal of Cerebral Circulation·Ivo AbenAdriaan Honig
Mar 30, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Eiji ShimizuMasaomi Iyo
Jul 21, 2004·The Journal of Neuropsychiatry and Clinical Neurosciences·R VatajaT Erkinjuntti
May 17, 2005·Brain Research. Molecular Brain Research·Félicien KaregeRomano La Harpe
Jul 1, 2005·Metabolism: Clinical and Experimental·Farideh EskandariUNKNOWN POWER (Premenopausal, Odteopenia/Osteoporosis, Women, Alendronate, Depression) Study Group
Sep 6, 2005·Free Radical Biology & Medicine·Antonio CherubiniPatrizia Mecocci
Mar 29, 2006·Biological Psychiatry·Eric J Nestler, William A Carlezon
Apr 25, 2006·Biological Psychiatry·Ronald S Duman, Lisa M Monteggia
Sep 23, 2006·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Jessica L JohnsonMark J Gorman
Feb 17, 2007·Stroke; a Journal of Cerebral Circulation·Caroline L WatkinsMichael J Leathley
Sep 1, 2007·Stroke; a Journal of Cerebral Circulation·Jari SiironenJaakko Lappalainen
Sep 21, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Keri Martinowich, Bai Lu
Aug 30, 2008·Neuropsychiatric Disease and Treatment·Stefano Paolucci
Oct 17, 2008·Nature·Vaishnav Krishnan, Eric J Nestler
Nov 27, 2008·Clinical and Investigative Medicine. Médecine Clinique Et Experimentale·Heng-qiang GaoLe-xin Wang
Mar 7, 2009·Journal of the Neurological Sciences·Micaela SantosPanteleimon Giannakopoulos

❮ Previous
Next ❯

Citations

Nov 26, 2020·Pharmaceutics·Elizabeth M RheaMichelle E Erickson
Apr 13, 2021·Journal of Ginseng Research·Na WangChun-Chao Han
Jul 10, 2021·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Honglei RenJian Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.